• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Influenza viruses with rearranged genomes as live-attenuated vaccines.具有重配基因组的流感病毒作为减毒活疫苗。
J Virol. 2013 May;87(9):5118-27. doi: 10.1128/JVI.02490-12. Epub 2013 Feb 28.
2
Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.通过修饰NS1基因开发一种针对H5N1和H9N2禽流感病毒的双保护减毒活疫苗。
Arch Virol. 2015 Jul;160(7):1729-40. doi: 10.1007/s00705-015-2442-y. Epub 2015 May 12.
3
Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.灭活嵌合血凝素H9/H5N2禽流感病毒的疫苗效力及其对标记疫苗策略的适用性
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.01693-16. Print 2017 Mar 15.
4
Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.针对快速进化的H5亚型病毒开发具有分支特异性和广泛反应性的减毒活流感病毒疫苗。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00547-17. Print 2017 Aug 1.
5
Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).几种抗 H5N1 流感实验疫苗在小鼠和鸡模型中的比较安全性、免疫原性和有效性(灭活和活 H5 疫苗的测试)。
Influenza Other Respir Viruses. 2012 May;6(3):188-95. doi: 10.1111/j.1750-2659.2011.00291.x. Epub 2011 Sep 23.
6
Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses.含 H9N2 内部基因的减毒 H5N1 疫苗可保护鸡免受高致病性 H5N1 和 H9N2 流感病毒的感染。
Influenza Other Respir Viruses. 2013 Mar;7(2):120-31. doi: 10.1111/j.1750-2659.2012.00363.x. Epub 2012 Apr 9.
7
Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.利用来自禽流感病毒的全部八个基因生成减毒H5N1禽流感病毒疫苗。
Vaccine. 2007 Oct 16;25(42):7379-84. doi: 10.1016/j.vaccine.2007.08.011. Epub 2007 Aug 24.
8
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.新型活流感疫苗M2SR可保护小鼠和雪貂免受高致病性禽流感的侵害。
Vaccine. 2017 Jul 24;35(33):4177-4183. doi: 10.1016/j.vaccine.2017.06.039. Epub 2017 Jun 28.
9
Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.展示H5、H7、H9血凝素和N1神经氨酸酶的病毒样颗粒可引发鸡对异源禽流感病毒的保护性免疫。
Virology. 2017 Jan 15;501:176-182. doi: 10.1016/j.virol.2016.12.001. Epub 2016 Dec 6.
10
The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine.新型温度敏感突变 PA-F35S 用于开发重组禽源减毒 H5N1 流感疫苗。
Virol J. 2012 May 23;9:97. doi: 10.1186/1743-422X-9-97.

引用本文的文献

1
Synthetic biology-inspired development of live attenuated influenza vaccines.受合成生物学启发的减毒活流感疫苗研发。
NPJ Vaccines. 2025 Aug 27;10(1):204. doi: 10.1038/s41541-025-01255-1.
2
PB2 and PA mutations contribute to the pathogenicity of mouse-adapted pdmH1N1-Venus reporter influenza A virus in a mammalian model.PB2和PA突变在哺乳动物模型中对适应小鼠的pdmH1N1-金星报告基因甲型流感病毒的致病性有影响。
Front Microbiol. 2025 Jan 7;15:1532304. doi: 10.3389/fmicb.2024.1532304. eCollection 2024.
3
Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine.使用重配缺陷型H9N2禽流感活疫苗进行大规模接种。
NPJ Vaccines. 2024 Aug 3;9(1):136. doi: 10.1038/s41541-024-00923-y.
4
Pandemic preparedness through vaccine development for avian influenza viruses.通过开发针对禽流感病毒的疫苗做好大流行的准备。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2347019. doi: 10.1080/21645515.2024.2347019. Epub 2024 May 28.
5
Impact of sex on humoral immunity with live influenza B virus vaccines in mice.性别对小鼠接种乙型流感病毒活疫苗后体液免疫的影响。
NPJ Vaccines. 2024 Feb 26;9(1):45. doi: 10.1038/s41541-024-00827-x.
6
Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1.抗病毒反应与病毒诱导的细胞关闭:甲型流感病毒NS1与严重急性呼吸综合征冠状病毒2 Nsp1之间的权力游戏
Front Cell Infect Microbiol. 2024 Feb 5;14:1357866. doi: 10.3389/fcimb.2024.1357866. eCollection 2024.
7
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.基于病毒粒子的联合疫苗可预防小鼠流感和 SARS-CoV-2 疾病。
J Virol. 2022 Aug 10;96(15):e0068922. doi: 10.1128/jvi.00689-22. Epub 2022 Jul 12.
8
Real-Time Visualization of the Infection and Replication of a Mouse-Lethal Recombinant H9N2 Avian Influenza Virus.小鼠致死性重组H9N2禽流感病毒感染与复制的实时可视化
Front Vet Sci. 2022 Feb 24;9:849178. doi: 10.3389/fvets.2022.849178. eCollection 2022.
9
Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants.新冠患者的病毒载量:在新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体背景下对预后和疫苗效力的影响
Front Med (Lausanne). 2022 Jan 31;8:836826. doi: 10.3389/fmed.2021.836826. eCollection 2021.
10
FluB-RAM and FluB-RANS: Genome Rearrangement as Safe and Efficacious Live Attenuated Influenza B Virus Vaccines.流感B-RAM和流感B-RANS:作为安全有效的减毒活流感B病毒疫苗的基因组重排
Vaccines (Basel). 2021 Aug 12;9(8):897. doi: 10.3390/vaccines9080897.

本文引用的文献

1
Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.针对 H5N1 流感爆发开发减毒活流感疫苗。
Viruses. 2012 Dec 10;4(12):3589-605. doi: 10.3390/v4123589.
2
Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.重组腺病毒载体 H5N1 流感疫苗的进展和未来挑战。
Viruses. 2012 Nov 1;4(11):2711-35. doi: 10.3390/v4112711.
3
The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development.H5N1疫苗的现状以及雪貂模型在流感治疗和预防研发中的应用。
J Infect Dev Ctries. 2012 Jun 15;6(6):465-9. doi: 10.3855/jidc.2666.
4
Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model.H9N2 禽流感表面基因与 2009 年大流行 H1N1 内部基因在雪貂模型中的传播相容性。
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12084-8. doi: 10.1073/pnas.1108058108. Epub 2011 Jul 5.
5
Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.猪源三重组流感病毒聚合酶基因的修饰用于制备针对 2009 年大流行 H1N1 病毒的减毒活疫苗。
J Virol. 2011 Jan;85(1):456-69. doi: 10.1128/JVI.01503-10. Epub 2010 Oct 20.
6
Antigenic and genetic characteristics of influenza A(H5N1)and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines.甲型流感病毒(H5N1)和甲型流感病毒(H9N2)的抗原及基因特征,以及为用于人类疫苗而研发的候选疫苗病毒。
Wkly Epidemiol Rec. 2010 Oct 15;85(42):418-24.
7
A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins.一种携带 H1 和 H3 亚型血凝素的九节段流感病毒。
J Virol. 2010 Aug;84(16):8062-71. doi: 10.1128/JVI.00722-10. Epub 2010 Jun 2.
8
Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.基于聚合酶基因修饰的新型减毒流感疫苗可预防流感大流行和流感疫情。
J Virol. 2010 May;84(9):4587-96. doi: 10.1128/JVI.00101-10. Epub 2010 Feb 24.
9
Viruses as vaccine vectors for infectious diseases and cancer.病毒作为传染性疾病和癌症的疫苗载体。
Nat Rev Microbiol. 2010 Jan;8(1):62-73. doi: 10.1038/nrmicro2240.
10
Rewiring the RNAs of influenza virus to prevent reassortment.改造流感病毒的RNA以防止基因重配。
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15891-6. doi: 10.1073/pnas.0908897106. Epub 2009 Sep 8.

具有重配基因组的流感病毒作为减毒活疫苗。

Influenza viruses with rearranged genomes as live-attenuated vaccines.

机构信息

Department of Veterinary Medicine, University of Maryland, College Park, and Virginia-Maryland Regional College of Veterinary Medicine, College Park, Maryland, USA.

出版信息

J Virol. 2013 May;87(9):5118-27. doi: 10.1128/JVI.02490-12. Epub 2013 Feb 28.

DOI:10.1128/JVI.02490-12
PMID:23449800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3624320/
Abstract

H5N1 and H9N2 avian influenza virus subtypes top the World Health Organization's list for the greatest pandemic potential. Inactivated H5N1 vaccines induce limited immune responses and, in the case of live-attenuated influenza virus vaccines (LAIV), there are safety concerns regarding the possibility of reassortment between the H5 gene segment and circulating influenza viruses. In order to overcome these drawbacks, we rearranged the genome of an avian H9N2 influenza virus and expressed the entire H5 hemagglutinin open reading frame (ORF) from the segment 8 viral RNA. These vectors had reduced polymerase activities as well as viral replication in vitro and excellent safety profiles in vivo. Immunization with the dual H9-H5 influenza virus resulted in protection against lethal H5N1 challenge in mice and ferrets, and also against a potentially pandemic H9 virus. Our studies demonstrate that rearranging the influenza virus genome has great potential for the development of improved vaccines against influenza virus as well as other pathogens.

摘要

H5N1 和 H9N2 禽流感病毒亚型是世界卫生组织(WHO)认为最具大流行潜力的病毒。灭活的 H5N1 疫苗可诱导有限的免疫应答,而对于减毒活流感疫苗(LAIV),人们担心 H5 基因片段与流行的流感病毒之间可能发生重配。为了克服这些缺点,我们对禽流感 H9N2 流感病毒的基因组进行了重排,并从 8 号病毒 RNA 上表达了整个 H5 血凝素开放阅读框(ORF)。这些载体的聚合酶活性以及体外病毒复制能力降低,体内安全性良好。用双重 H9-H5 流感病毒免疫可保护小鼠和雪貂免受致命的 H5N1 挑战,也可预防潜在的大流行 H9 病毒。我们的研究表明,重排流感病毒基因组对于开发针对流感病毒以及其他病原体的改良疫苗具有巨大潜力。